Condition: Tumour of Epithelial Origin · 68Ga-MY6349 · Sponsor: Xijing Hospital
This is a study using an autocontrol approach, enrolling 40 patients with tumours of epithelial origin, who underwent 68Ga- MY6349 and 68Ga-PSMA/18F-FDG PET/CT imaging of patients with tumours of epithelial origin to compare the ability to diagnose, stage and monitor recurrence of tumours of epithelial origin using the pathological findings as the gold standard.
This description comes directly from the study's public registry record.
Ying Guo Ying Guo · 0086+15991459177 · guoying01192022@163.com
Always discuss trial participation with your own doctor first.
| Department of Nuclear Medicine,Xijing Hospital, Fourth Military Medical University, Xi'an, China | Xi'an, Shaanxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06770478